Review Article
Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis
Figure 5
(a) Dose-response relationship between postdiagnostic aspirin exposure and prostate cancer-specific mortality risk; (b) duration-response relationship between postdiagnostic aspirin exposure and prostate cancer-specific mortality risk; (c) frequency-response relationship between prediagnostic aspirin exposure and prostate cancer-specific mortality risk; (d) frequency-response relationship between postdiagnostic aspirin exposure and prostate cancer-specific mortality risk. (The solid lines represent the linear/nonlinear trend. The dashed lines dashes represent the pointwise 95% confidence intervals for the linear trend.)
(a) |
(b) |
(c) |
(d) |